'Use lowest effective dose of Nsaids': Fresh advisory on kidney risks of painkiller abuse
India's Central Drugs Standard Control Organisation (CDSCO) has issued a fresh advisory on the rational consumption of painkillers (NSAIDs) and antibiotics due to the risk of kidney complications from misuse. The advisory emphasizes using these prescription medicines only when clinically indicated, at appropriate doses, and under medical supervision, especially for those with existing kidney conditions.
Why it matters
This advisory addresses a significant public health concern in India, aiming to reduce the burden of chronic kidney disease by promoting responsible medication use and preventing adverse effects from self-medication.
NEW DELHI: Central Drugs Standard Control Organisation (CDSCO) has issued a fresh advisory on rational consumption of painkillers and antibiotics, in view of their repeated use, without proper medical advice, putting people at the risk of kidney complications and other adverse effects.The drug regulator's circular says non-steroidal anti-inflammatory drugs (Nsaids) and antibiotics are prescription medicines under Drugs and Cosmetics Rules and should be used only when clinically indicated, at the appropriate dose and duration and under medical supervision.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in